|
1
|
Schaff LR and Mellinghoff IK: Glioblastoma
and other primary brain malignancies in adults: A review. JAMA.
329:574–587. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ostrom QT, Cioffi G, Gittleman H, Patil N,
Waite K, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical
report: Primary brain and other central nervous system tumors
diagnosed in the United States in 2012–2016. Neuro Oncol. 21 (Suppl
5):v1–v100. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Linz U: Commentary on effects of
radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet
Oncol. 2009;10:459-466). Cancer. 116:1844–1846. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pasquier B, Pasquier D, N'Golet A, Panh MH
and Couderc P: Extraneural metastases of astrocytomas and
glioblastomas: Clinicopathological study of two cases and review of
literature. Cancer. 45:112–125. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalokhe G, Grimm SA, Chandler JP,
Helenowski I, Rademaker A and Raizer JJ: Metastatic glioblastoma:
Case presentations and a review of the literature. J Neurooncol.
107:21–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tan AC, Ashley DM, López GY, Malinzak M,
Friedman HS and Khasraw M: Management of glioblastoma: State of the
art and future directions. CA Cancer J Clin. 70:299–312. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stupp R, Taillibert S, Kanner A, Read W,
Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K,
et al: Effect of tumor-treating fields plus maintenance
temozolomide vs maintenance temozolomide alone on survival in
patients with glioblastoma: A randomized clinical trial. JAMA.
318:2306–2316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kurokawa R, Kurokawa M, Baba A, Ota Y,
Pinarbasi E, Camelo-Piragua S, Capizzano AA, Liao E, Srinivasan A
and Moritani T: Major changes in 2021 World Health Organization
classification of central nervous system tumors. Radiographics.
42:1474–1493. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Childs JD, Piva SR and Fritz JM:
Responsiveness of the numeric pain rating scale in patients with
low back pain. Spine (Phila Pa 1976). 30:1331–1334. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rodriguez CS: Pain measurement in the
elderly: A review. Pain Manag Nurs. 2:38–46. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li MMJ, Ocay DD, Larche CL, Vickers K,
Saran N, Ouellet JA, Gélinas C and Ferland CE: Validation of the
critical-care pain observation tool (CPOT) in pediatric patients
undergoing orthopedic surgery. Can J Pain. 7:21563322023.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Figueroa P, Lupton JR, Remington T, Olding
M, Jones RV, Sekhar LN and Sulica VI: Cutaneous metastasis from an
intracranial glioblastoma multiforme. J Am Acad Dermatol.
46:297–300. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Al-Ali F, Hendon AJ, Liepman MK,
Wisniewski JL, Krinock MJ and Beckman K: Oligodendroglioma
metastatic to bone marrow. AJNR Am J Neuroradiol. 26:2410–2414.
2005.PubMed/NCBI
|
|
14
|
Lun M, Lok E, Gautam S, Wu E and Wong ET:
The natural history of extracranial metastasis from glioblastoma
multiforme. J Neurooncol. 105:261–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kurdi M, Baeesa S, Okal F, Bamaga AK,
Faizo E, Fathaddin AA, Alkhotani A, Karami MM and Bahakeem B:
Extracranial metastasis of brain glioblastoma outside CNS:
Pathogenesis revisited. Cancer Rep (Hoboken). 6:e19052023.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Newton HB, Rosenblum MK and Walker RW:
Extraneural metastases of infratentorial glioblastoma multiforme to
the peritoneal cavity. Cancer. 69:2149–2153. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Davis L: SPONGIOBLASTOMA MULTIFORME OF THE
BRAIN. Ann Surg. 87:8–14. 1928.PubMed/NCBI
|
|
18
|
Liwnicz BH and Rubinstein LJ: The pathways
of extraneural spread in metastasizing gliomas: A report of three
cases and critical review of the literature. Hum Pathol.
10:453–467. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hamilton JD, Rapp M, Schneiderhan T, Sabel
M, Hayman A, Scherer A, Kröpil P, Budach W, Gerber P, Kretschmar U,
et al: Glioblastoma multiforme metastasis outside the CNS: three
case reports and possible mechanisms of escape. J Clin Oncol.
32:e80–e84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Terheggen HG and Müller W:
Extracerebrospinal metastases in glioblastoma. Case report and
review of the literature. Eur J Pediatr. 124:155–164. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hoffman HJ and Duffner PK: Extraneural
metastases of central nervous system tumors. Cancer. 56 (7
Suppl):S1778–S1782. 1985. View Article : Google Scholar
|
|
22
|
Tuettenberg J, Grobholz R, Korn T, Wenz F,
Erber R and Vajkoczy P: Continuous low-dose chemotherapy plus
inhibition of cyclooxygenase-2 as an antiangiogenic therapy of
glioblastoma multiforme. J Cancer Res Clin Oncol. 131:31–40. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Piccirilli M, Brunetto GM, Rocchi G,
Giangaspero F and Salvati M: Extra central nervous system
metastases from cerebral glioblastoma multiforme in elderly
patients. Clinico-pathological remarks on our series of seven cases
and critical review of the literature. Tumori. 94:40–51. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Polley MY, Lamborn KR, Chang SM, Butowski
N, Clarke JL and Prados M: Conditional probability of survival in
patients with newly diagnosed glioblastoma. J Clin Oncol.
29:4175–4180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu W, Zhong D, Zhao Z, Wang W, Li J and
Zhang W: Postoperative extracranial metastasis from glioblastoma: A
case report and review of the literature. World J Surg Oncol.
15:2312017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blume C, von Lehe M, van Landeghem F,
Greschus S and Boström J: Extracranial glioblastoma with
synchronous metastases in the lung, pulmonary lymph nodes,
vertebrae, cervical muscles and epidural space in a young
patient-case report and review of literature. BMC Res Notes.
6:2902013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rosen J, Blau T, Grau SJ, Barbe MT, Fink
GR and Galldiks N: Extracranial metastases of a cerebral
glioblastoma: A case report and review of the literature. Case Rep
Oncol. 11:591–600. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anghileri E, Castiglione M, Nunziata R,
Boffano C, Nazzi V, Acerbi F, Finocchiaro G and Eoli M: Extraneural
metastases in glioblastoma patients: two cases with YKL-40-positive
glioblastomas and a meta-analysis of the literature. Neurosurg Rev.
39:37–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Andersen BM, Miranda C, Hatzoglou V,
DeAngelis LM and Miller AM: Leptomeningeal metastases in glioma:
The memorial sloan kettering cancer center experience. Neurology.
92:e2483–e2491. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Noch EK, Sait SF, Farooq S, Trippett TM
and Miller AM: A case series of extraneural metastatic glioblastoma
at Memorial Sloan Kettering cancer center. Neurooncol Pract.
8:325–336. 2021.PubMed/NCBI
|
|
31
|
Cantero D, de Lope ÁR, de la Presa RM,
Sepúlveda JM, Borrás JM, Castresana JS, D'Haene N, García JF,
Salmon I, Mollejo M, et al: Molecular study of long-term survivors
of glioblastoma by gene-targeted next-generation sequencing. J
Neuropathol Exp Neurol. 77:710–716. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cantero D, Mollejo M, Sepúlveda JM,
D'Haene N, Gutiérrez-Guamán MJ, de Lope ÁR, Fiaño C, Castresana JS,
Lebrun L, Rey JA, et al: TP53, ATRX alterations, and low tumor
mutation load feature IDH-wildtype giant cell glioblastoma despite
exceptional ultra-mutated tumors. Neurooncol Adv.
2:vdz0592020.PubMed/NCBI
|
|
33
|
Karatas Y, Cengiz SL and Ustun ME: A case
of symptomatic synchronous cervical and cerebellar metastasis after
resection of thoracal metastasis from temporal glioblastoma
multiforme without any local recurrence. Asian J Neurosurg.
11:4522016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stark AM, Nabavi A, Mehdorn HM and Blömer
U: Glioblastoma multiforme-report of 267 cases treated at a single
institution. Surg Neurol. 63:162–169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hübner F, Braun V and Richter HP: Case
reports of symptomatic metastases in four patients with primary
intracranial gliomas. Acta Neurochir (Wien). 143:25–29. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Karaca M, Andrieu MN, Hicsonmez A, Guney Y
and Kurtman C: Cases of glioblastoma multiforme metastasizing to
spinal cord. Neurol India. 54:428–430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Buhl R, Barth H, Hugo HH, Hutzelmann A and
Mehdorn HM: Spinal drop metastases in recurrent glioblastoma
multiforme. Acta Neurochir (Wien). 140:1001–1005. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schwaninger M, Patt S, Henningsen P and
Schmidt D: Spinal canal metastases: A late complication of
glioblastoma. J Neurooncol. 12:93–98. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ringel F, Pape H, Sabel M, Krex D, Bock
HC, Misch M, Weyerbrock A, Westermaier T, Senft C, Schucht P, et
al: Clinical benefit from resection of recurrent glioblastomas:
Results of a multicenter study including 503 patients with
recurrent glioblastomas undergoing surgical resection. Neuro Oncol.
18:96–104. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cabrera AR, Kirkpatrick JP, Fiveash JB,
Shih HA, Koay EJ, Lutz S, Petit J, Chao ST, Brown PD, Vogelbaum M,
et al: Radiation therapy for glioblastoma: Executive summary of an
American Society for radiation oncology evidence-based clinical
practice guideline. Pract Radiat Oncol. 6:217–225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mohile NA, Messersmith H, Gatson NT,
Hottinger AF, Lassman A, Morton J, Ney D, Nghiemphu PL, Olar A,
Olson J, et al: Therapy for diffuse astrocytic and oligodendroglial
tumors in adults: ASCO-SNO guideline. J Clin Oncol. 40:403–426.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lah TT, Novak M and Breznik B: Brain
malignancies: Glioblastoma and brain metastases. Semin Cancer Biol.
60:262–273. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Venur VA and Leone JP: Targeted therapies
for brain metastases from breast cancer. Int J Mol Sci.
17:15432016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chinot OL, Wick W, Mason W, Henriksson R,
Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea
D, et al: Bevacizumab plus radiotherapy-temozolomide for newly
diagnosed glioblastoma. N Engl J Med. 370:709–722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gilbert MR, Dignam JJ, Armstrong TS, Wefel
JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S,
Won M, et al: A randomized trial of bevacizumab for newly diagnosed
glioblastoma. N Engl J Med. 370:699–708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yu Z, Zhao G, Zhang Z, Li Y, Chen Y, Wang
N, Zhao Z and Xie G: Efficacy and safety of bevacizumab for the
treatment of glioblastoma. Exp Ther Med. 11:371–380. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pitter KL, Tamagno I, Alikhanyan K,
Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M,
Chan TA, et al: Corticosteroids compromise survival in
glioblastoma. Brain. 139:1458–1471. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Seidel C and Kortmann RD: Corticosteroids
compromise survival in glioblastoma patients after radio- and
chemotherapy. Strahlenther Onkol. 193:982–983. 2017.(In German).
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhou L, Shen Y, Huang T, Sun Y, Alolga RN,
Zhang G and Ge Y: The prognostic effect of dexamethasone on
patients with glioblastoma: A systematic review and meta-analysis.
Front Pharmacol. 12:7277072021. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Swildens KX, Smitt PAE, van den Bent MJ,
French PJ and Geurts M: The effect of dexamethasone on the
microenvironment and efficacy of checkpoint inhibitors in
glioblastoma: A systematic review. Neurooncol Adv.
4:vdac0872022.PubMed/NCBI
|
|
51
|
Arora H, Mammi M, Patel NM, Zyfi D, Dasari
HR, Yunusa I, Simjian T, Smith TR and Mekary RA: Dexamethasone and
overall survival and progression free survival in patients with
newly diagnosed glioblastoma: A meta-analysis. J Neurooncol.
166:17–26. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Klement RJ and Champ CE: Corticosteroids
compromise survival in glioblastoma in part through their elevation
of blood glucose levels. Brain. 140:e162017.PubMed/NCBI
|
|
53
|
Troschel FM, Troschel BO, Kloss M, Jost J,
Pepper NB, Völk-Troschel AS, Wiewrodt RG, Stummer W, Wiewrodt D and
Eich HT: Sarcopenia is associated with chemoradiotherapy
discontinuation and reduced progression-free survival in
glioblastoma patients. Strahlenther Onkol. 200:774–784. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bianconi A, Palmieri G, Aruta G,
Monticelli M, Zeppa P, Tartara F, Melcarne A, Garbossa D and Cofano
F: Updates in glioblastoma immunotherapy: An overview of the
current clinical and translational scenario. Biomedicines.
11:15202023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Goswami S, Walle T, Cornish AE, Basu S,
Anandhan S, Fernandez I, Vence L, Blando J, Zhao H, Yadav SS, et
al: Immune profiling of human tumors identifies CD73 as a
combinatorial target in glioblastoma. Nat Med. 26:39–46. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Brown MP, Ebert LM and Gargett T: Clinical
chimeric antigen receptor-T cell therapy: A new and promising
treatment modality for glioblastoma. Clin Transl Immunology.
8:e10502019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Álvarez-Vázquez A, San-Segundo L,
Cerveró-García P, Flores-Hernández R, Ollauri-Ibáñez C,
Segura-Collar B, Hubert CG, Morrison G, Pollard SM, Lathia JD, et
al: EGFR amplification and EGFRvIII predict and participate in
TAT-Cx43266-283 antitumor response in preclinical glioblastoma
models. Neuro Oncol. 26:1230–1246. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Dhar D, Ghosh S, Das S and Chatterjee J: A
review of recent advances in magnetic nanoparticle-based
theranostics of glioblastoma. Nanomedicine (Lond). 17:107–132.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Angom RS, Nakka NMR and Bhattacharya S:
Advances in glioblastoma therapy: An update on current approaches.
Brain Sci. 13:15362023. View Article : Google Scholar : PubMed/NCBI
|
